Original Articles. Tomo Osako 1,2, Masahiko Oguchi 1,2, Madoka Kumada 1,2, Keiko Nemoto 1,2, Takuji Iwase 2 and Takashi Yamashita 1,2 INTRODUCTION
|
|
- Karin Powell
- 5 years ago
- Views:
Transcription
1 Jpn J Clin Oncol 2008;38(5) doi: /jjco/hyn030 Original Articles Acute Radiation Dermatitis and Pneumonitis in Japanese Breast Cancer Patients with Whole Breast Hypofractionated Radiotherapy Compared to Conventional Radiotherapy Tomo Osako 1,2, Masahiko Oguchi 1,2, Madoka Kumada 1,2, Keiko Nemoto 1,2, Takuji Iwase 2 and Takashi Yamashita 1,2 1 Department of Radiation Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo and 2 Department of Breast Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan Received January 21, 2008; accepted March 21, 2008; published online April 16, 2008 Objective: To evaluate acute morbidity, radiation dermatitis and pneumonitis, of Japanese patients treated with whole breast hypofractionated radiotherapy (RT) after breast-conserving surgery (BCS), compared to conventional RT. Methods: Japanese patients who received whole breast RT after BCS between October 2003 and September 2006 were retrospectively reviewed. Patients who had selected the conventional or hypofractionated schedule received whole breast irradiation of 50 Gy in 25 fractions plus boost or 40 Gy in 16 fractions plus boost. Radiation dermatitis and symptomatic pneumonitis were graded according to the Common Terminology Criteria for Adverse Events version 3.0. Results: Of 443 consecutive patients, 377 (85%) received the conventional schedule and 66 (15%) received the hypofractionated schedule. Of patients treated with the conventional schedule, Grade 0, 1, 2 and 3 radiation dermatitis were observed in 16 (4%), 278 (74%), 77 (20%) and 6 (2%), respectively. Of patients treated with the hypofractionated schedule, Grade 0, 1, 2 and 3 dermatitis were observed in 11 (17%), 49 (74%), 5 (8%) and 1 (1%), respectively. Grade 2 3 dermatitis by the hypofractionated schedule (9%) was observed less frequently than that by the conventional schedule (22%) (chi-square test; P ¼ 0.016). Moreover, of patients treated with the conventional schedule, 4 (1%) had Grade 2 radiation pneumonitis. No patient treated with the hypofractionated schedule had symptomatic pneumonitis. Conclusions: Radiation dermatitis and pneumonitis in Japanese patients treated with the hypofractionated schedule is acceptable. Especially, radiation dermatitis by the hypofractionated schedule is milder than that by the conventional schedule. Key words: breast cancer breast-conserving surgery whole breast hypofractionated radiotherapy radiation dermatitis radiation pneumonitis INTRODUCTION Breast-conserving surgery (BCS) followed by radiotherapy (RT) has become accepted as an appropriate treatment for women with early breast cancer (1). A meta-analysis had For reprints and all correspondence: Tomo Osako, Department of Pathology, The Cancer Institute of Japanese Foundation for Cancer Research, , Ariake, Koto-ku, Tokyo , Japan. tomo.osako@jfcr.or.jp demonstrated that RT reduced the 5-year local recurrence and 15-year breast cancer and overall mortality in post-bcs patients (2). Furthermore, two randomized trials showed that additional boost radiation to the tumor bed improved local control rates (3,4). There is no uniform agreement on which RT schedule should be used; however, the role of breast RT after BCS is widely accepted. Several different RT schedules were used # The Author (2008). Published by Oxford University Press. All rights reserved.
2 Jpn J Clin Oncol 2008;38(5) 335 in randomized trials that established the efficacy of postoperative breast RT after BCS. The National Surgical Adjuvant Breast and Bowel Project B06 trial evaluated 50 Gy in 25 fractions to the whole breast (1). The Swedish trial evaluated 54 Gy in 27 fractions (5). The Ontario Clinical Oncology Group trial evaluated 40 Gy in 16 fractions plus boost radiation (6). The Milan trial evaluated 50 Gy in 25 fractions plus boost (7). A schedule commonly used today in Japanese clinical practice is 50 Gy in 25 fractions to the whole breast plus boost radiation to the tumor bed. In Canada and the UK, the hypofractionated schedule for breast RT have been applied in clinical practice. This approach is based on the radio-biological linear quadratic model that is a larger dose per fraction given over a shorter period is just as effective as the conventional schedule (8). The hypofractionated schedules have ranged from 39 to 44 Gy in fractions with fraction size Gy over 3 5 weeks (9 16). Most retrospective studies and randomized trials have reported that acceptable local control rates and cosmesis (9 16). Moreover, the hypofractionated schedule has significant implications for patient convenience and resource utilization. However, the hypofractionated schedule had been studied in the Western countries, there are not enough data about that for Japanese patients. Therefore, in order to confirm the feasibility of the hypofractionated RT for Japanese breast cancer patients, we retrospectively evaluated acute morbidity, radiation dermatitis and pneumonitis, of the post-bcs patients treated with the hypofractionated compared to that with the conventional RT. PATIENTS AND METHODS STUDY PATIENTS Japanese patients with breast cancer treated with BCS followed by whole breast RT were retrospectively reviewed in the present study. The eligibility criteria of the present study were as follows: (i) pathologically proven primary breast carcinoma, (ii) BCS was performed at the Cancer Institute Hospital, Tokyo, (iii) RT was started between October 2003 and September 2006 and (iv) boost radiation to the tumor bed was given by electrons. The exclusion criteria were (i) synchronous bilateral breast RT and (ii) concurrent administration of chemotherapy and RT. All the post-bcs patients were given enough information of both the conventional and hypofractionated schedules of whole breast RT. Especially, we told them that the results of the Canadian randomized trail reported by Whelan (12); the cosmetic outcomes at five years were same between the two schedules, but longer term cosmetic outcomes than 5-years of both arms were not available at that time. Then, the post-bcs patients decided by their preference which they hope to receive. Patients background, concurrent endocrine therapy, prior chemotherapy and the used energy of the X-rays, of the two groups were compared by chi-square test. A value of P, 0.05 was considered significant. RT REGIMENS Patients who had selected the conventional schedule received the whole breast RT of 50 Gy in 25 fractions with fraction size 2 Gy over 35 days. After the whole breast RT, they received boost radiation of Gy with fraction size 2 Gy by electron beams. Regarding the regimen of the hypofractionated schedule, we referred to the clinical trial in the National Cancer Center Hospital, Tokyo (17), in which they used whole breast RT of 40 Gy in 16 fractions with fraction size 2.5 Gy plus boost radiation to the tumor bed of 10 Gy in four fractions with fraction size 2.5 Gy by electrons. In the present study, patients who had selected the hypofractionated schedule received whole breast RT of 40 Gy in 16 fractions with fraction size 2.5 Gy over 22 days. After the whole breast RT, they received boost radiation of Gy with fraction size 2.5 Gy by electrons. Patients were treated in the supine position with the ipsilateral arm raised above the shoulder and immobilized. The target volume, whole breast, was irradiated by the two opposing tangential photon fields, which were set up with simulators and/or RT computed tomography planning system (Eclipse, Varian Medical Systems, Palo Alto, CA and RenderPlan, Elekta Oncology Systems, Inc, Norcross, GA). The medial border was located at the mid-sternal line. The lateral border was at the posterior axillary line to include the breast with 1- to 2-cm margin and to limit the amount of lung at the central plane to less than 2.5 cm. The superior border was located at a horizontal line drawn through the super-sternal notch. The inferior border was located at a horizontal line 1 2 cm below the inframammary fold. The half beam technique has been applied for every patients treated with whole breast radiation. The median depth of the radiation ports, namely a half of chest wall separation, was 20 cm (range cm). Appropriate physical wedge compensations ( ) were installed in all the patients to ensure a uniform dose distribution throughout the target volume. The dose was prescribed at a point midway along the central plane, two-thirds of the distance from the skin to the base of tangent fields. Portal films were obtained in the treatment position with a therapeutic beam to confirm adequate coverage. Patients were treated with 4- to 6-MV X-rays. Boost radiation was added to the tumor bed by 4 11 MeV electron beams. EVALUATION AND ANALYSIS OF RADIATION DERMATITIS Radiation dermatitis by worst was graded according to the Common Terminology Criteria for Adverse Events version
3 336 Acute morbidity of hypofractionated breast RT 3.0 by the investigators, with a visual inspection of the breast at baseline, every week during RT, and 3 months after the end of RT. In the present study, Grade 0 was defined as no adverse event observed. We compared Grade 0 1 events with Grade 2 3 events of the two schedules by chi-square test. A value of P, 0.05 was considered significant. EVALUATION AND ANALYSIS OF RADIATION PNEUMONITIS Radiation pneumonitis was also graded according to the Common Terminology Criteria for Adverse Events version 3.0 by the investigators, with medical examination and chest X-ray film at three months after the end of RT. When symptomatic radiation pneumonitis was suspected, computer tomography was performed to confirm the diagnosis. In the present study, asymptomatic pneumonitis (Grade 1) was not evaluated. We compared symptomatic radiation pneumonitis of the two schedules by chi-square test. A value of P, 0.05 was considered significant. RESULTS PATIENT CHARACTERISTIC A total of 443 consecutive patients were assessed in the present study. All the patients were Japanese women. There was no patient with collagen vascular disease. Of the 433 patients, 377 (85%) selected RT with the conventional schedule and 66 (15%) selected RT with the hypofractionated schedule. The demographic characteristics of the present study population are present in Table 1. There are no statistical difference between the two groups regarding concurrent endocrine therapy (chi-square test; P ¼ 0.39), prior chemotherapy (P ¼ 0.51), and the used energy of the X-rays (P ¼ 0.21). Furthermore, there was no obvious difference between other patients characteristics of the two groups. Table 1. Patient characteristics Hypofractionated Conventional No. % No. % No. of patients Mean age (range) 55.5 (32 81) 52.2 (19 79) T classification Tis T T T T Stage Stage Stage I Stage II Stage III Concurrent endocrine therapy yes no Prior chemotherapy yes no Used energy 4 MV MV Boost radiation 10 Gy/5 fr Gy/6 fr Gy/8 fr Gy/4 fr Gy/5 fr Gy/6 fr 1 2 RADIATION DERMATITIS Of 377 patients treated with the conventional RT, 16 (4%) did not have any radiation dermatitis (Grade 0). Moreover, 278(74%),77(20%)and6(2%)hadGrade1,2and3radiation dermatitis, respectively (Table 2). On the other hand, of 66 patients treated with the hypofractionated RT, 11 (17%) did not have any radiation dermatitis (Grade 0). Furthermore, 49 (74%), 5 (8%) and 1 (1%) had Grade 1, 2 and 3 radiation dermatitis, respectively (Table 2). Compared to the proportion of Grade 2 3 radiation dermatitis by the hypofractionated schedule with that by the conventional schedule, radiation dermatitis by the hypofractionated schedule (9%) was significantly milder than that by the conventional schedule (22%) (chi-square test; P ¼ 0.016). fr, fraction. Table 2. Grades of radiation dermatitis Grade Hypofractionated Conventional No. % No. %
4 Jpn J Clin Oncol 2008;38(5) 337 RADIATION PNEUMONITIS Of 377 patients treated with the conventional schedule, 4 (1%) had Grade 2 radiation pneumonitis. Pneumonitis graded 3 or more was not observed. On the other hand, no patient treated with the hypofractionated schedule had symptomatic radiation pneumonitis. The difference was not significant (chi-square test; P ¼ 0.89). The four patients started to get symptoms related to radiation pneumonitis 2 5 months after the end of the RT. All the four patients recovered form radiation pneumonitis without steroid therapy. DISCUSSION The present retrospective study showed that acute dermatitis by the hypofractionated RT was milder than that by the conventional RT in Japanese patients. This result suggests that the hypofractionated RT may contribute to the patients quality of life (QOL) from the viewpoint of acute radiation dermatitis, in addition to reducing the burden of the way to and from hospitals. Several studies had shown that breast RT had physical and psychological effects on the patients QOL (18 24). Acute radiation dermatitis is one of the important physical factors that effect on the patients QOL during and shortly after the treatment (18,19). Especially, high RT dosage and long schedule was predictor of low QOL at the completion of RT (19) and acute skin toxicity was increased in high RT dosage and intensive schedule (25). However, cosmetic outcome had been often assessed in most studies about hypofractionated breast RT (9,10,12 16), acute dermatitis has not been assessed in spite of the possible impact on patients QOL. Two Japanese retrospective studies which compared acute dermatitis of hypofractionated whole breast RT (44 Gy in 16 fractions) with that of conventional RT (50 Gy in 25 fractions) (26,27). One of the studies showed that acute reaction rates were not higher in the hypofractionated schedule than the conventional one (26). Proportion of Grade 2 radiation dermatitis and use of steroid ointment in the hypofractionated schedule was about half of the conventional one (6 versus 12%, 37 versus 71%) (26). The other showed that there was no significant difference between subjective sequelae of the two groups (27). Another study using intensity modulated radiation therapy for breast showed Grade 2 acute skin toxicity was lower on the hypofractionated schedule compared to the standard fractionation (23 versus 70%) (28). It is unclear why the acute skin toxicity should be lower on the hypofractionated schedule. One of the reasons is that biologically effective dose of acute reaction of the hypofractionated schedule calculated by linear quadratic model (8) was smaller than that of the conventional schedule (29). But, the difference was small in the present and the former Japanese studies. Moreover, it is difficult to compare biologically effective dose of the two groups in the present study, because the boost radiation was added to the both group. Radiation pneumonitis by the hypofractionated RT is not inferior to that by the conventional RT. The former Japanese retrospective study (26) had shown that radiation pneumonitis by the hypofractionated RT was milder than that by the conventional RT (3 versus 11%). In the present study, although 1% (4 of 377) of the patients treated with the conventional RT suffered from symptomatic radiation pneumonitis, none of the patients treated with the hypofractionated RT suffered. In conclusion, acute morbidity, radiation dermatitis and pneumonitis, of post-bcs Japanese patients treated with the hypofractionated RT is acceptable. Especially, acute dermatitis by the hypofractionated RT is milder than that by the conventional RT. However, our data have some shortcomings, mainly based on the incomplete retrospective data. The multi-institutional bridging study, in which scoring of patients toxicity is performed on a prospective basis, is warranted to confirm the feasibility of whole breast hypofractionated RT for Japanese patients. Conflict of interest statement None declared. References 1. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347: Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Early Breast Cancer Trialists Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366: Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC trial. J Clin Oncol 2007;25: Romestaing P, Lehingue Y, Carrie C, Coquard R, Montbarbon X, Ardiet JM, et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol 1997;15: Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabar L, Nordgren H, et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol 1999;17: Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. JNatlCancerInst1996;88: Veronesi U, Luini A, Del Vecchio M, Greco M, Galimberti V, Merson M, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 1993;328: Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62: Olivotto IA, Weir LM, Kim-Sing C, Bajdik CD, Trevisan CH, Doll CM, et al. Late cosmetic results of short fractionation for breast conservation. Radiother Oncol 1996;41: Shelley W, Brundage M, Hayter C, Paszat L, Zhou S, Mackillop W. A shorter fractionation schedule for postlumpectomy breast cancer patients. Int J Radiat Oncol Biol Phys 2000;47: Ash DV, Benson EA, Sainsbury JR, Round C, Head C. Seven-year follow-up on 334 patients treated by breast conserving surgery and short course radical postoperative radiotherapy: a report of the
5 338 Acute morbidity of hypofractionated breast RT Yorkshire Breast Cancer Group. Clin Oncol (R Coll Radiol) 1995;7: Whelan T, MacKenzie R, Julian J, Levine M, Shelley W, Grimard L, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 2002;94: Yarnold J, Ashton A, Bliss J, Homewood J, Harper C, Hanson J, et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol 2005;75: Owen JR, Ashton A, Bliss JM, Homewood J, Harper C, Hanson J, et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 2006;7: Dewar JA, Haviland JS, Agrawal RK, Bliss JM, Hopwood P, Magee JR, et al. First results of the UK standardisation of breast radiotherapy (START) trials. J Clin Oncol 2007;25:p18S (Abstract). 16. Livi L, Stefanacci M, Scoccianti S, Dicosmo D, Borghesi S, Nosi F, et al. Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgery. Clin Oncol (R Coll Radiol) 2007;19: Kagami Y, Imai A, Sumi M, Itoh Y, Ikeda H, Murayama S, et al. Study to evaluate feasibility and efficacy of a shorter fractionation schedule of radiotherapy in conserving therapy. Jpn J Clin Radiol 2004;49:302 6 (in Japanese with English abstract). 18. Whelan TJ, Levine M, Julian J, Kirkbride P, Skingley P. The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial. Ontario Clinical Oncology Group. Cancer 2000;88: Lee TS, Kilbreath SL, Refshauge KM, Pendlebury SC, Beith JM, Lee MJ. Quality of life of women treated with radiotherapy for breast cancer. Support Care Cancer 2008;16: Budischewski K, Fischbeck S, Mose S. Quality of life of breast cancer patients in the course of adjuvant radiotherapy. Support Care Cancer 2008;16: Geinitz H, Zimmermann FB, Thamm R, Keller M, Busch R, Molls M. Fatigue in patients with adjuvant radiation therapy for breast cancer: long-term follow-up. J Cancer Res Clin Oncol 2004;130: Back M, Ahern V, Delaney G, Graham P, Steigler A, Wratten C. New South Wales Breast Radiation Oncology Group. Absence of adverse early quality of life outcomes of radiation therapy in breast conservation therapy for early breast cancer. Australas Radiol 2005;49: Wallace LM, Priestman SG, Dunn JA, Priestman TJ. The quality of life of early breast cancer patients treated by two different radiotherapy regimens. Clin Oncol (R Coll Radiol) 1993;5: Hopwood P, Haviland J, Mills J, Sumo G, Bliss JM. The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial). Breast 2007;16: Buchholz TA, Strom EA, Oswald MJ, Perkins GH, Oh J, Domain D, et al. Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancer. Int J Radiat Oncol Biol Phys 2006;65: Shoji K, Abe S, Fukuma E. Experience of short fractionation irradiation in breast conservation. Jpn J Breast Cancer 2006;21:450 4 (in Japanese with English abstract). 27. Inomata T, Narabayashi I, Inada Y, Shimbo T, Takahashi M, Tatsumi T, et al. Patients subjective evaluation of early and late sequelae in patients with breast cancer irradiated with short fractionation for breast conservation therapy: comparison with conventional fractionation. Breast Cancer 2008;15: Freedman GM, Anderson PR, Goldstein LJ, Ma CM, Li J, Swaby RF, et al. Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost. Int J Radiat Oncol Biol Phys 2007;68: Nozaki M, Kawashima M. Short-course radiotherapy for the whole breast after breast conserving surgery. Breast Cancer 2008;15:80 5.
Hypofractionated radiotherapy for breast cancer: too fast or too much?
Editorial Hypofractionated radiotherapy for breast cancer: too fast or too much? Vassilis E. Kouloulias 1, Anna G. Zygogianni 2 1 2nd Department of Radiology, Radiotherapy unit, Attikon University Hospital,
More informationAcute and late adverse effects of breast cancer radiation: Two hypo-fractionation protocols
ORIGINAL ARTICLES Acute and late adverse effects of breast cancer radiation: Two hypo-fractionation protocols Mohamed Abdelhamed Aboziada 1, Samir Shehata 2 1 Department of Radiation Oncology, South Egypt
More informationLong-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
The new england journal of medicine original article Long-Term Results of Radiation Therapy for Breast Cancer Timothy J. Whelan, B.M., B.Ch., Jean-Philippe Pignol, M.D., Mark N. Levine, M.D., Jim A. Julian,
More informationIs there an advantage to delivering breast boost in the lateral decubitus position?
Kannan et al. Radiation Oncology 2012, 7:163 RESEARCH Open Access Is there an advantage to delivering breast boost in the lateral decubitus position? Neeta Kannan, Peyman Kabolizadeh, Hayeon Kim, Christopher
More informationWhole Breast Irradiation: Class vs. Hypofractionation
Whole Breast Irradiation: Class vs. Hypofractionation Kyung Hwan Shin, MD, PhD. Dept. of Radiation Oncology, Seoul National University Hospital 2018. 4. 6. GBCC Treatment Trends of Early Breast Cancer
More informationBy Rufus Mark, MD, Gail Lebovic, MD, Valerie Gorman, MD, Oscar Calvo, PhD. TABLE 1 EARLY STAGE BREAST CANCER RANDOMIZED TRIALS M vs.
EVOLUTION OF BREAST CONSERVATION RADIATION TREATMENT TECHNIQUES IN BREAST CANCER : FROM 6 WEEKS TO 3 WEEKS TO 1 WEEK TO 1 DAY AND FROM WHOLE BREAST TO PARTIAL BREAST By Rufus Mark, MD, Gail Lebovic, MD,
More informationThe Role of a Boost Radiation Dose in Patients with Negative Re-Excision Findings
24 The Open Breast Cancer Journal, 2011, 3, 24-28 Open Access The Role of a Boost Radiation Dose in with Negative Re-Excision Melanie C. Smitt and Kathleen C. Horst * Department of Radiation Oncology,
More informationBreast-conserving surgery is now commonly used in the treatment
2260 The Effects of Radiation Therapy on Quality of Life of Women with Breast Carcinoma Results of a Randomized Trial Timothy J. Whelan, B.M., B.Ch., M.Sc. 1,2,3 Mark Levine, M.D. 2,3 Jim Julian, M.Math.
More informationProtocol of Radiotherapy for Breast Cancer
107 年 12 月修訂 Protocol of Radiotherapy for Breast Cancer Indication of radiotherapy Indications for Post-Mastectomy Radiotherapy (1) Axillary lymph node 4 positive (2) Axillary lymph node 1-3 positive:
More informationGUIDELINES FOR RADIOTHERAPY IN EARLY BREAST CANCER
GUIDELINES FOR RADIOTHERAPY IN EARLY BREAST CANCER Authors: Dr N Thorp/ Dr P Robson On behalf of the Breast CNG Written: Originally - December 2008 Reviewed: Updated - December 2011 Agreed: Breast TSG
More informationBreast Cancer? Breast cancer is the most common. What s New in. Janet s Case
Focus on CME at The University of Calgary What s New in Breast Cancer? Theresa Trotter, MD, FRCPC Breast cancer is the most common malignancy affecting women in Canada, accounting for almost a third of
More informationJournal of the Egyptian Nat. Cancer Inst., Vol. 16, No. 3, September: , 2004
Journal of the Egyptian Nat. Cancer Inst., Vol. 16, No. 3, September: 178-187, 24 Hypofractionation versus Conventional Fractionation Radiotherapy after Conservative Treatment of Breast Cancer: Early Skin
More informationGuidelines for the treatment of Breast cancer with radiotherapy v.1.0 September 2017
Guidelines for the treatment of Breast cancer with radiotherapy v.1.0 September 2017 Author: Dr Virginia Wolstenholme, Consultant Clinical Oncologist, Barts Health Date agreed: September 2017 Date to be
More informationHypofractionated Radiotherapy as Adjuvant Treatment in Early Breast Cancer. A Review and Meta-Analysis of Randomized Controlled Trials
Review Article Breast Care 2015;10:240 245 DOI: 10.1159/000439007 Published online: August 19, 2015 Hypofractionated Radiotherapy as Adjuvant Treatment in Early Breast Cancer. A Review and Meta-Analysis
More informationConsensus Guideline on Accelerated Partial Breast Irradiation
Consensus Guideline on Accelerated Partial Breast Irradiation Purpose: To outline the use of accelerated partial breast irradiation (APBI) for the treatment of breast cancer. Associated ASBS Guidelines
More informationRadiation Therapy for the Oncologist in Breast Cancer
REVIEW ARTICLE Chonnam National University Medical School Sung-Ja Ahn, M.D. Adjuvant Tamoxifen with or without in Patients 70 Years of Age with Stage I ER-Positive Breast Cancer: Efficacy Outcomes (10
More informationRadiotherapy and Oncology
Radiotherapy and Oncology 106 (2013) 15 20 Contents lists available at SciVerse ScienceDirect Radiotherapy and Oncology journal homepage: www.thegreenjournal.com Review Accelerated fractionation with a
More informationRadiation and DCIS. The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging
Radiation and DCIS The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging Einsley-Marie Janowski, MD, PhD Assistant Professor Department of Radiation Oncology
More informationSurgery for Breast Cancer
Surgery for Breast Cancer 1750 Mastectomy - Petit 1894 Radical mastectomy Halsted Extended, Super radical mastectomy 1948 Modified radical mastectomy Patey 1950-60 WLE & RT Baclesse, Mustakallio 1981-85
More informationRadiation Treatment for Breast. Cancer. Melissa James Radiation Oncologist August 2015
Radiation Treatment for Breast Cancer Melissa James Radiation Oncologist August 2015 OUTLINE External Beam Radiation treatment. (What is Radiation, doctor?) Role of radiation. (Why am I getting radiation,
More informationRadiotherapy Physics and Equipment
Radiological Sciences Department Radiotherapy Physics and Equipment RAD 481 Lecture s Title: Introduction Dr. Mohammed EMAM Ph.D., Paris-Sud 11 University Vision :IMC aspires to be a leader in applied
More informationRESEARCH ARTICLE. Abstract. Introduction
DOI:10.22034/APJCP.2016.17.11.4819 RESEARCH ARTICLE Comparison of Conventional and Hypofractionated Radiotherapy in Breast Cancer Patients in Terms of 5-Year Survival, Locoregional Recurrence, Late Skin
More informationJ Roger Owen, Anita Ashton, Judith M Bliss, Janis Homewood, Caroline Harper, Jane Hanson, Joanne Haviland, Soren M Bentzen, John R Yarnold
Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial J Roger Owen, Anita Ashton, Judith
More informationRADIOTHERAPY IN BREAST CANCER :
RADIOTHERAPY IN BREAST CANCER : PAST, PRESENT, FUTURE Dr Jyotirup Goswami Consultant Radiation Oncologist Narayana Cancer Institute Narayana Superspecialty Hospital Breast cancer is the classic paradigm
More informationPrinciples of breast radiation therapy
ANZ 1601/BIG 16-02 EXPERT ESMO Preceptorship Program 2017 Principles of breast radiation therapy Boon H Chua Professor Director of Cancer and Haematology Services UNSW Sydney and Prince of Wales Hospital
More informationPost-Lumpectomy Radiation Techniques and Toxicities
Post-Lumpectomy Radiation Techniques and Toxicities Laura Willson, MD Abbott Northwestern Hospital Dept. of Radiation Oncology February 2, 2019 Learning Objectives How radiation therapy works Standard
More informationSpinal Cord Doses in Palliative Lung Radiotherapy Schedules
Journal of the Egyptian Nat. Cancer Inst., Vol. 8, No., June: -, 00 Spinal Cord Doses in Palliative Lung Radiotherapy Schedules HODA AL-BOOZ, FRCR FFRRCSI M.D.* and CAROL PARTON, Ph.D.** The Departments
More informationUniversity of Groningen. Local treatment in young breast cancer patients Joppe, Enje Jacoba
University of Groningen Local treatment in young breast cancer patients Joppe, Enje Jacoba IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
More informationCOMPARISON OF THREE CONCOMITANT BOOST TECHNIQUES FOR EARLY-STAGE BREAST CANCER
doi:10.1016/j.ijrobp.2005.07.004 Int. J. Radiation Oncology Biol. Phys., Vol. 64, No. 1, pp. 168 175, 2006 Copyright 2006 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/06/$ see front
More informationBreast Cancer Radiotherapy: Clinical challenges in 2011 from a European Perspective. Dr DA WHEATLEY CONSULTANT ONCOLOGIST ROYAL CORNWALL HOSPITAL
Breast Cancer Radiotherapy: Clinical challenges in 2011 from a European Perspective Dr DA WHEATLEY CONSULTANT ONCOLOGIST ROYAL CORNWALL HOSPITAL Radiotherapy in Early Breast Cancer Why do we do it? Who
More informationReal-world outcomes of postmastectomy radiotherapy in breast cancer patients with 1 3 positive lymph nodes: a retrospective study
Journal of Radiation Research, 2014, 55, 121 128 doi: 10.1093/jrr/rrt084 Advance Access Publication 20 June 2013 Real-world outcomes of postmastectomy radiotherapy in breast cancer patients with 1 3 positive
More informationCase Conference: Post-Mastectomy Radiotherapy
Case Conference: Post-Mastectomy Radiotherapy Outline - Case Intro Guidelines Studies - Case Conclusion Summary Outline Case Intro to PMRT Guidelines Studies Case conclusion Summary Outline - Case Intro
More informationIORT What We ve Learned So Far
IORT What We ve Learned So Far The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging Einsley-Marie Janowski, MD, PhD Assistant Professor Department of Radiation
More informationJournal of Medical Imaging and Radiation Oncology
Journal of Medical Imaging and Radiation Oncology 62 (2018) 425 431 RADIATION ONCOLOGY ORIGINAL ARTICLE Ischaemic heart disease following conventional and hypofractionated radiation treatment in a contemporary
More informationResults of the ACOSOG Z0011 Trial
DCIS and Early Breast Cancer Symposium JUNE 15-17 2012 CAPPADOCIA Results of the ACOSOG Z0011 Trial Kelly K. Hunt, M.D. Professor of Surgery Axillary Node Dissection Staging, Regional control, Survival
More informationMETASTASES OF PATIENTS WITH EARLY STAGES OF BREAST CANCER
Trakia Journal of Sciences, No 4, pp 7-76, 205 Copyright 205 Trakia University Available online at: http://www.uni-sz.bg ISSN 33-7050 (print) doi:0.5547/tjs.205.04.02 ISSN 33-355 (online) Original Contribution
More informationSan Antonio Breast Cancer Symposium 2010 Highlights Radiotherapy
San Antonio Breast Cancer Symposium 2010 Highlights Radiotherapy Kathleen C. Horst, M.D. Assistant Professor Department of Radiation Oncology Stanford University The Optimal SEquencing of Adjuvant Chemotherapy
More informationBreast radiotherapy in women with pectus excavatum (funnel chest): is the lateral decubitus technique an answer? A dosimetric study
The British Journal of Radiology, 79 (2006), 785 790 SHORT COMMUNICATION Breast radiotherapy in women with pectus excavatum (funnel chest): is the lateral decubitus technique an answer? A dosimetric study
More informationBREAST CONSERVATION TREATMENT IN EARLY STAGE DISEASE AND DCIS LAWRENCE J. SOLIN, MD, FACR, FASTRO
BREAST CONSERVATION TREATMENT IN EARLY STAGE DISEASE AND DCIS LAWRENCE J. SOLIN, MD, FACR, FASTRO Chairman Department of Radiation Oncology Albert Einstein Healthcare Network Philadelphia, PA Professor
More informationDebate Axillary dissection - con. Prof. Dr. Rodica Anghel Institute of Oncology Bucharest
Debate Axillary dissection - con Prof. Dr. Rodica Anghel Institute of Oncology Bucharest Summer School of Oncology, third edition Updated Oncology 2015: State of the Art News & Challenging Topics Bucharest,
More informationHow can surgeons help the Radiation Oncologists?
How can surgeons help the Radiation Oncologists? Lorna Weir BC Surgical Oncology fall breast cancer update Oct 24, 2009 Disclosure no conflict of interest Outline Introduction OR reports Marking of surgical
More informationPost-mastectomy radiotherapy: recommended standards
Post-mastectomy radiotherapy: recommended standards H. Bartelink Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands Introduction The local recurrence rate after mastectomy
More informationBruno CUTULI Policlinico Courlancy REIMS. WORKSHOP SULL IRRADIAZIONE MAMMARIA IPOFRAZIONATA Il carcinoma duttale in situ
Bruno CUTULI Policlinico Courlancy REIMS WORKSHOP SULL IRRADIAZIONE MAMMARIA IPOFRAZIONATA Il carcinoma duttale in situ XXI CONGRESSO AIRO GENOVA 22.11.2011 INTRODUCTION Due to wide diffusion of mammography,
More informationNo clear effect of postoperative radiotherapy on survival of breast cancer patients with one to three positive nodes: a population-based study
Annals of Oncology original articles Annals of Oncology 26: 1149 1154, 2015 doi:10.1093/annonc/mdv159 Published online 3 April 2015 No clear effect of postoperative radiotherapy on survival of breast cancer
More informationTrends in the Use of Implantable Accelerated Partial Breast Irradiation Therapy for Early Stage Breast Cancer in the United States
Trends in the Use of Implantable Accelerated Partial Breast Irradiation Therapy for Early Stage Breast Cancer in the United States A THESIS SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY
More informationBREAST CONSERVATION TREATMENT IN EARLY STAGE DISEASE AND DCIS LAWRENCE J. SOLIN, MD, FACR, FASTRO
BREAST CONSERVATION TREATMENT IN EARLY STAGE DISEASE AND DCIS LAWRENCE J. SOLIN, MD, FACR, FASTRO Chairman Department of Radiation Oncology Albert Einstein Medical Center Philadelphia, PA Professor (Adjunct)
More informationRadiotherapy Implications of ACOSOG Z-11 for Clinical Practice. Julia White, MD Professor of Radiation Oncology Medical College of Wisconsin
1 Radiotherapy Implications of ACOSOG Z-11 for Clinical Practice Julia White, MD Professor of Radiation Oncology Medical College of Wisconsin Disclosures: none Agenda 1. ACOSOG Z-11: Another perspective
More informationLeft Breast Cancer Treated in Isocentric Lateral Decubitus (ILD) Position: An Alternative Technique Sparing Organs at Risk (OAR)
Global Journal of Breast Cancer Research, 2013, 1, 53-57 53 Left Breast Cancer Treated in Isocentric Lateral Decubitus (ILD) Position: An Alternative Technique Sparing Organs at Risk (OAR) Giorgia Capezzali
More informationThe Use of the Latissimus dorsi Flap in Breast Reconstruction of Post-Mastectomy Patients: Is Superior to the Use of Expander / Prosthesis?
Research Article imedpub Journals http://www.imedpub.com Journal of Aesthetic & Reconstructive Surgery DOI: 10.4172/2472-1905.100014 The Use of the Latissimus dorsi Flap in Breast Reconstruction of Post-Mastectomy
More information3D Conformal Radiation Therapy for Mucinous Carcinoma of the Breast
1 Angela Kempen February Case Study February 22, 2012 3D Conformal Radiation Therapy for Mucinous Carcinoma of the Breast History of Present Illness: JE is a 45 year-old Caucasian female who underwent
More informationImplications of ACOSOG Z11 for Clinical Practice: Surgical Perspective
:$;7)#*8'-87*4BCD'E7)F'31$4.$&'G$H'E7)F&'GE'>??ID >?,"'@4,$)4*,#74*8'!74/)$++'74',"$'A.,.)$'7%'()$*+,'!*42$)!7)74*67&'!3 6 August 2011 Implications of ACOSOG Z11 for Clinical
More informationCitation for published version (APA): Laan, H. P. V. D. (2010). Optimising CT guided radiotherapy for breast cancer Groningen: s.n.
University of Groningen Optimising CT guided radiotherapy for breast cancer Laan, Hans Paul van der IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite
More informationACCELERATED BREAST IRRADIATION EVOLVING PARADIGM FOR TREATMENT OF EARLY STAGE BREAST CANCER
ACCELERATED BREAST IRRADIATION EVOLVING PARADIGM FOR TREATMENT OF EARLY STAGE BREAST CANCER KHANH NGUYEN, MD, MA DEPARTMENT OF RADIATION ONCOLOGY BAYHEALTH CANCER CENTER BREAST CANCER STATISTICS Most common
More informationIntraoperative. Radiotherapy
Intraoperative Radiotherapy ROBERTO ORECCHIA UNIVERSITY of MILAN & EUROPEAN INSTITUTE of ONCOLOGY & CNAO FOUNDATION Breast Cancer Brescia, 30th September 2011 IORT, very selective technique to intensify
More informationHow can we Personalize RT as part of Breast-Conserving Therapy?
How can we Personalize RT as part of Breast-Conserving Therapy? Jay R. Harris Dana-Farber Cancer Institute (DFCI) Brigham and Women s Hospital (BWH) Harvard Medical School Disclosures I have no COI disclosures
More informationHypofractionated RT in Cervix Cancer. Anuja Jhingran, MD
Hypofractionated RT in Cervix Cancer Anuja Jhingran, MD Hypofractionated RT in Cervix Cancer: Clinicaltrials.gov 919 cervix trials 134 hypofractionated RT trials Prostate, breast, NSCLC, GBM 0 cervix trials
More informationHypofractionated Radiotherapy for breast cancer: Updated evidence
2 rd Bangladesh Breast Cancer Conference, Dhaka, December 2017 Hypofractionated Radiotherapy for breast cancer: Updated evidence Tabassum Wadasadawala Associate Professor of Radiation Oncology Tata Memorial
More informationThe Incidence of Lung Carcinoma after Surgery for Breast Carcinoma with and without Postoperative Radiotherapy
1362 The Incidence of Lung Carcinoma after Surgery for Breast Carcinoma with and without Postoperative Radiotherapy Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) Clinical Trials
More informationWhy Do Axillary Dissection? Nodal Treatment and Survival NSABP B04. Revisiting Axillary Dissection for SN Positive Patients
Memorial Sloan-Kettering Cancer Center 1275 York Avenue, New York, NY 10065 10th International Congress on the Future of Breast Cancer Coronado, CA Why Do Axillary Dissection? 6 August 2011 Implications
More information9.5. CONVENTIONAL RADIOTHERAPY TECHNIQUE FOR TREATING THYROID CANCER
9.5. CONVENTIONAL RADIOTHERAPY TECHNIQUE FOR TREATING THYROID CANCER ROBERT J. AMDUR, MD, SIYONG KIM, PhD, JONATHAN GANG LI, PhD, CHIRAY LIU, PhD, WILLIAM M. MENDENHALL, MD, AND ERNEST L. MAZZAFERRI, MD,
More informationAdvances in Localized Breast Cancer
Advances in Localized Breast Cancer Melissa Camp, MD, MPH and Fariba Asrari, MD June 18, 2018 Moderated by Elissa Bantug 1 Advances in Surgery for Breast Cancer Melissa Camp, MD June 18, 2018 2 Historical
More informationImplications of ACOSOG Z11 for Clinical Practice: Surgical Perspective
Memorial Sloan-Kettering Cancer Center 1275 York Avenue, New York, NY 10065 10th International Congress on the Future of Breast Cancer Coronado, CA 6 August 2011 Implications of ACOSOG Z11 for Clinical
More informationPMRT for N1 breast cancer :CONS. Won Park, M.D., Ph.D Department of Radiation Oncology Samsung Medical Center
PMRT for N1 breast cancer :CONS Won Park, M.D., Ph.D Department of Radiation Oncology Samsung Medical Center DBCG 82 b & c Overgaard et al Radiot Oncol 2007 1152 pln(+), 8 or more nodes removed Systemic
More informationPRONE BREAST WHAT S THE BIG DEAL? Rachel A. Hackett CMD, RTT
PRONE BREAST WHAT S THE BIG DEAL? Rachel A. Hackett CMD, RTT BREAST CANCER TREATMENT OPTIONS Surgical Options For the breast: Breast conserving surgery (lumpectomy) Breast Conservation Therapy = surgery
More informationBreast cancer: Clinical evidence. of new treatments. Aero academy Conference Innovation and Safety. Patients Come First
Breast cancer: Clinical evidence of new treatments Aero academy Conference Innovation and Safety Patients Come First January 26 & 27, 2018 Lisbon, Portugal Disclosure & Disclaimer An honorarium is provided
More informationAccelerated partial breast irradiation: state of the art
Accelerated partial breast irradiation: state of the art P.A. Coucke, N. Jansen, L. Jánváry, C. Louis, J. Vanderick, A. Rorive, J. Collignon, E. Lifrange, S. Maweja, G. Jerusalem Accelerated partial breast
More informationCitation Hong Kong Practitioner, 1996, v. 18 n. 2, p
Title Conservative surgery for breast cancer Author(s) Poon, RTP; Chow, LWC; Au, GKH Citation Hong Kong Practitioner, 1996, v. 18 n. 2, p. 68-72 Issued Date 1996 URL http://hdl.handle.net/722/45367 Rights
More informationCorrelation between intensity modulated radiotherapy and bone marrow suppression in breast cancer
European Review for Medical and Pharmacological Sciences 2016; 20: 75-81 Correlation between intensity modulated radiotherapy and bone marrow suppression in breast cancer Q. WANG 1, T. YE 1, H.-L. CHEN
More informationImplications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers
日大医誌 75 (1): 10 15 (2016) 10 Original Article Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers Naotaka Uchida 1), Yasuki Matsui 1), Takeshi Notsu 1) and Manabu
More informationSurvival of High Grade Glioma Patients Treated by Three Radiation Schedules with Chemotherapy: A Retrospective Comparative Study
Original Article Research in Oncology June 2017; Vol. 13, No. 1: 18-22. DOI: 10.21608/resoncol.2017.552.1022 Survival of High Grade Glioma Patients Treated by Three Radiation Schedules with Chemotherapy:
More informationClinical Trials of Proton Therapy for Breast Cancer. Andrew L. Chang, MD 張維安 Study Chair
Clinical Trials of Proton Therapy for Breast Cancer Andrew L. Chang, MD 張維安 Study Chair AndrewLChangMD@gmail.com Disclosure Proton Center Development Corporation Scripps San Diego Proton Therapy Center
More informationUpdates on the Conflict of Postoperative Radiotherapy Impact on Survival of Young Women with Cancer Breast: A Retrospective Cohort Study
International Journal of Medical Research & Health Sciences Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2017, 6(7): 14-18 I J M R
More informationThe Impact of Image Guided Radiotherapy in Breast Boost Radiotherapy
The Impact of Image Guided Radiotherapy in Breast Boost Radiotherapy 1 Donovan EM, 1 Brooks C, 1 Mitchell A, 2 Mukesh M, 2 Coles CE, 3 Evans PM, 1 Harris EJ 1 Joint Department of Physics, The Royal Marsden/Institute
More informationVariation In Mean Heart Dose By Treatment Plan Optimization During Radiotherapy For Left Sided Breast Cancer
International Journal of Scientific and Research Publications, Volume 6, Issue 6, June 2016 18 Variation In Mean Heart Dose By Treatment Plan Optimization During Radiotherapy For Left Sided Breast Cancer
More informationNeoadjuvant Treatment of. of Radiotherapy
Neoadjuvant Treatment of Breast Cancer: Role of Radiotherapy Neoadjuvant Chemotherapy Many new questions for radiation oncology? lack of path stage to guide indications should treatment response affect
More informationCorporate Medical Policy
Corporate Medical Policy Breast Brachytherapy for Accelerated Partial Breast Radiotherapy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: breast_brachytherapy_for_accelerated_partial_breast_radiotherapy
More informationJournal of Breast Cancer
ORIGINAL ARTICLE Journal of Breast Cancer J Breast Cancer 2009 June; 12(2): 73-8 DOI: 10.4048/jbc.2009.12.2.73 Radiation Pneumonitis after Adjuvant Radiotherapy for Breast Cancer: A Volumetric Analysis
More informationSentinel Lymph Node Biopsy for Breast Cancer
Sentinel Lymph Node Biopsy for Breast Cancer Registrar Tutorial Adam Cichowitz Surgical Registrar The Royal Melbourne Hospital Sentinel Lymph Node Biopsy Axillary LN status important prognostic factor
More informationMohammad Houshyari 1, Amir ShahramYousefi Kashi 1, Sakineh Soleimani Varaki 2, Afshin Rakhsha 1, Eftekhar Rajab Blookat 3
Electronic Physician (ISSN: 2008-5842) http://www.ephysician.ir Year: 2015, Volume: 7, Issue: 2, Pages: 1032-1038, DOI: 10.14661/2015.1032-1038 Regional lymph node radiotherapy in breast cancer: single
More informationTreatment Results and Prognostic Factors of Early Breast Cancer Treated with a Breast Conserving Operation and Radiotherapy
Treatment Results and Prognostic Factors of Early Breast Cancer Treated with a Breast Conserving Operation and Radiotherapy Kyoung Ju Kim 1, Seung Jae Huh 1, Jung-Hyun Yang 2, Won Park 1, Seok Jin Nam
More informationSSO-ASTRO Consensus Guidance Margins for Breast-Conserving Surgery with Whole Breast Irradiation in Stage I and II Invasive Breast Cancer
SSO-ASTRO Consensus Guidance Margins for Breast-Conserving Surgery with Whole Breast Irradiation in Stage I and II Invasive Breast Cancer Dr. Yvonne Tsang St. Paul s Hospital Introductions Breast-conserving
More informationNew Technologies in Radiation Oncology. Catherine Park, MD, MPH Advocate Good Shepherd Hospital
New Technologies in Radiation Oncology Catherine Park, MD, MPH Advocate Good Shepherd Hospital Breast Radiation Early Stage Breast Cancer Whole Breast Radiation Delivered to the whole breast Boost to the
More informationPartial Breast Irradiation using adaptive MRgRT
Partial Breast Irradiation using adaptive MRgRT Shyama Tetar, radiation-oncologist VUmc Amsterdam 15-12-2017 5 th Vumc SBRT symposium 2017 Current practice Breast conserving treatment (BCT) Breast conserving
More informationFRACTIONATION FOR WHOLE BREAST IRRADIATION: AN AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO) EVIDENCE-BASED GUIDELINE
doi:10.1016/j.ijrobp.2010.04.042 Int. J. Radiation Oncology Biol. Phys., Vol. 81, No. 1, pp. 59 68, 2011 Copyright Ó 2011 American Society for Radiation Oncology. Published by Elsevier Inc. Printed in
More informationOriginal Article Hypofractionated radiotherapy in breast cancer: Is it safe?
Harsukh Educational Charitable Society International Journal of Community Health and Medical Research Journal home page: www.ijchmr.com doi: 10.21276/ijchmr Official Publication of Harsukh Educational
More information03/14/2019. Postmastectomy radiotherapy; the meta-analyses, and the paradigm change to altered fractionation Mark Trombetta M.D.
radiotherapy; the meta-analyses, and the paradigm change to altered fractionation Mark Trombetta M.D. Division of Radiation Oncology Allegheny Health Network Cancer Institute Professor of Radiation Oncology
More informationRadiotherapy Management of Breast Cancer Treated with Neoadjuvant Chemotherapy. Julia White MD Professor, Radiation Oncology
Radiotherapy Management of Breast Cancer Treated with Neoadjuvant Chemotherapy Julia White MD Professor, Radiation Oncology Agenda Efficacy of radiotherapy in the management of breast cancer in the Adjuvant
More informationOncologist. The. Controversies Regarding the Use of Radiation After Mastectomy in Breast Cancer
The Oncologist Controversies Regarding the Use of Radiation After Mastectomy in Breast Cancer THOMAS A. BUCHHOLZ, ERIC A. STROM, GEORGE H. PERKINS, MARSHA D. MCNEESE Department of Radiation Oncology, The
More informationOutcome of rectal cancer after radiotherapy with a long or short waiting period before surgery, a descriptive clinical study
Original Article Outcome of rectal cancer after radiotherapy with a long or short waiting period before surgery, a descriptive clinical study Elmer E. van Eeghen 1, Frank den Boer 2, Sandra D. Bakker 1,
More informationClinical experience with TomoDirect System Tangential Mode
Breast Cancer Clinical experience with TomoDirect System Tangential Mode European Institute of Oncology Milan, Italy Disclosure & Disclaimer An honorarium is provided by Accuray for this presentation The
More informationEvolution of Regional Nodal Management of Breast Cancer
Evolution of Regional Nodal Management of Breast Cancer Bruce G. Haffty, MD Director (Interim) Rutgers Cancer Institute of New Jersey Professor and Chair Department of Radiation Oncology Rutgers, The State
More informationEffectiveness of Chemoradiotherapy for T1b-T2 Glottic Carcinoma
Research Article imedpub Journals http://www.imedpub.com Head and Neck Cancer Research ISSN 2572-2107 DOI: 10.21767/2572-2107.100011 Abstract Effectiveness of Chemoradiotherapy for T1b-T2 Glottic Carcinoma
More informationState of the Art in 2000 State of the Art today Gazing forward
2010 Buschke Lecture: The Relationship between Local Recurrence and Survival in Breast Cancer Jay R. Harris Dana-Farber Cancer Institute (DFCI) Brigham and Women s Hospital (BWH) Harvard Medical School
More informationComparison of survival outcomes between modified radical mastectomy and breast conserving surgery in early breast cancer patients
http://dx.doi.org/10.7180/kmj.2016.31.1.19 KMJ Original Article Comparison of survival outcomes between modified radical mastectomy and breast conserving surgery in early breast cancer patients Yoon Seok
More informationFive Year Outcome of 145 Patients With Ductal Carcinoma In Situ (DCIS) After Accelerated Breast Radiotherapy
International Journal of Radiation Oncology biology physics www.redjournal.org Clinical Investigation: Breast Cancer Five Year Outcome of 145 Patients With Ductal Carcinoma In Situ (DCIS) After Accelerated
More informationThe Effects of DIBH on Liver Dose during Right-Breast Treatments: A Case Study Abstract: Introduction: Case Description: Conclusion: Introduction
1 The Effects of DIBH on Liver Dose during Right-Breast Treatments: A Case Study Megan E. Sullivan, B.S., R.T.(T)., Patrick A. Melby, B.S. Ashley Hunzeker, M.S., CMD, Nishele Lenards, M.S., CMD, R.T. (R)(T),
More informationThe New England Journal of Medicine
The New England Journal of Medicine Copyright 22 by the Massachusetts Medical Society VOLUME 347 O CTOBER 17, 22 NUMBER 16 TWENTY-YEAR FOLLOW-UP OF A RANDOMIZED STUDY COMPARING BREAST-CONSERVING SURGERY
More informationThe Neoadjuvant Model as a Translational Tool for Drug and Biomarker Development in Breast Cancer
The Neoadjuvant Model as a Translational Tool for Drug and Biomarker Development in Breast Cancer Laura Spring, MD Breast Medical Oncology Massachusetts General Hospital Primary Mentor: Dr. Aditya Bardia
More informationManagement of Ductal Carcinoma in Situ of the Breast: A Clinical Practice Guideline
Evidence-based Series #1-10 Version 2.2006: Section 1 Management of Ductal Carcinoma in Situ of the Breast: A Clinical Practice Guideline W. Shelley, D. McCready, C. Holloway, M. Trudeau, S. Sinclair,
More informationThree dimensional conformal radiotherapy for synchronous bilateral breast irradiation using a mono iso-center technique
Polish Journal of Medical Physics and Engineering 2017;23(2):15-19 June 2017 doi: 10.1515/pjmpe-2017-0004 ISSN 1898-0309 Scientific Paper Three dimensional conformal radiotherapy for synchronous bilateral
More information